Pluri Inc.

Regulatory Filings • Feb 26, 2013

_________ false

C003�������� ��������� ����2PublicPLURISTEM THERAPEUTICS INC8544Corporation no: C12337-2001Stock Exchange/Market: NASDAQ2753381Matam Park 20 , Haifa 31905 , ISRAEL ,Tel: 074-7107171 , Fax: 074-7107172E.mail address: Info@Pluristem.ComDate of transmission: 26/02/2013              Time of broadcast: 15:46 15:41:02

Company site:		www.pluristem.com

Reference: 2013-02-047865

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	United Therapeutics Phase I Study

UTC_Phase_I_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 19/02/2013
- - -
Name of the Signatory: : Aberman Zalman , Position of Signatory in the reporting corporation: Chairman Of The Board & CEO , Name of Employer Company: .
Matam Park Telephone: 074-7107171 , Facsimile: 074-7107172 , E-mail: zami@pluristem.com 2